glp-1 weight loss drug news november 2025 Drugs: Pulse Survey (U.S.) GLP-1 Agonists Market Report 2025-2033,

Genetically engineered mice lacking NMDARs show deficits in habituation, working memory and associative learning (370)

The weight loss it produces is maintained while on treatment

For men on testosterone replacement therapy (TRT) , PSA results can fe

"Given the power of social media and influencers on a particular generation of people who consume social media a lot I envisage in time that there will be some changes to the law so that there can be recourse for people affected by products, but also, I think, to protect the community." She said at the moment, the only recourse consumers had was against the manufacturers of products such as Melanotan-II, even if they were based outside of Australia